NDC00173-0681-22: ZANAMIVIR FOR INHALATION.
The ZANAMIVIR FOR INHALATION is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: ZANAMIVIR) W/ INHALATION DEVICE, 5MG/BLISTER, 20 BLISTERS PER PACKAGE. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-657-8192, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | ZANAMIVIR) W/ INHALATION DEVICE, 5MG/BLISTER, 20 BLISTERS PER PACKAGE |
| NSN | 6505-01-657-8192 |
| SPECIAL FEATURES | FOR PANDEMIC STOCKPILE USE ONLY; RELENZA (ZANAMIVIR) INHALATION POWDER W/INHALATION DEVICE; 20 MG ZANAMIVIR PER ROTADISK (EACH BLISTER CONTAINS 5 MG ZANAMIVIR WITH LACTOSE); EACH PACKAGES CONTAINS 5 ROTADISKS; EACH ROTADISKS CONTAINS 4 BLISTERS FOR A TOTAL OF 20 BLISTERS PER PACKAGE; STORE AT 25C (77F); EXCURSIONS PERMITTED TO 15 TO 30C (59 TO 86F) (SEE USP CONTROLLED ROOM TEMPERATURE) |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ZANAMIVIR) W/ INHALATION DEVICE, 5MG/BLISTER, 20 BLISTERS PER PACKAGE |